TACROLIMUS SANDOZ CAPSULE 0.5 MG
Product details
Registration number: SIN15673P
Classification: Prescription Only
Active ingredients: Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus
Strength: 0.5 mg
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: L04AD02
HSA approval date: 25 April 2019
Manufacturer(s): Sandoz Private Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for TACROLIMUS SANDOZ CAPSULE 0.5 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15673P
Classification: Prescription Only
What active ingredients and strength are recorded for TACROLIMUS SANDOZ CAPSULE 0.5 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tacrolimus monohydrate 0.511mg equivalent to Tacrolimus
Strength: 0.5 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TACROLIMUS SANDOZ CAPSULE 0.5 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Who is the recorded registrant for TACROLIMUS SANDOZ CAPSULE 0.5 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for TACROLIMUS SANDOZ CAPSULE 0.5 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Sandoz Private Limited
Manufacturing country/countries: INDIA
Where can I look up TACROLIMUS SANDOZ CAPSULE 0.5 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15673P or the exact product name TACROLIMUS SANDOZ CAPSULE 0.5 MG. The general register link does not preselect this product.
What are the source dates for this TACROLIMUS SANDOZ CAPSULE 0.5 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TACROLIMUS SANDOZ CAPSULE 0.5 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15673P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)